Essity Porter's Five Forces Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Essity
Don't Miss the Bigger Picture
Essity operates in a mature, cost-sensitive hygiene market where supplier relationships and scale economies blunt supplier power while strong brands and retailer consolidation heighten buyer influence; threat of new entrants is muted by capital and regulatory barriers, but substitutes and competitive rivalry remain elevated due to private labels and innovation pressures. This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Essity’s competitive dynamics, market pressures, and strategic advantages in detail.
Suppliers Bargaining Power
Raw Material Volatility
Wood fiber and pulp — Essity’s main inputs — saw annual price swings of 18–25% from 2022–2024; by end-2025 certified sustainable fiber premiums rose ~12%, tightening margins. Supply-chain bottlenecks and EU/US environmental rules cut available certified pulp by an estimated 8–10% in 2025, boosting bargaining power of large pulp mills. Those suppliers can dictate contract lengths and spot premiums, directly pressuring Essity’s cost base and production planning.
Energy Intensity in Manufacturing
Essity’s tissue and hygiene production is energy-intensive—manufacturing can consume 2.5–4 MWh per tonne of finished goods; in 2024 European wholesale gas prices averaged ~€40–€60/MWh and industrial electricity €120–€200/MWh, so suppliers hold strong bargaining power amid post-2022 geopolitical shifts and the renewables transition. Energy providers set regionally varying tariffs based on grid capacity and fuel mix, forcing Essity to hedge and invest in on-site efficiency to protect margins.
Chemical and Polymer Sourcing
Essity depends on specialized suppliers for superabsorbent polymers (SAPs) and adhesives, with top suppliers like BASF and Evonik controlling ~60–70% of global SAP capacity in 2024, which limits switching without costly R&D and reformulation.
These large chemical firms own proprietary tech and patents, so supplier concentration gives them pricing power—SAP prices rose ~15% in 2023–24—pressuring Essity’s margins unless offset by scale or cost passes.
Sustainability Compliance Demands
As Essity pushes toward 2030 and 2050 net-zero targets, it demands strict ESG reporting and scope 1–3 carbon data from suppliers, trimming the supplier base to certified green vendors; in 2024 about 18% of global pulp supply carried sustainability certifications, tightening availability for hygiene-product makers like Essity.
This concentration raises supplier bargaining power: certified suppliers can charge premiums (estimated 5–12% higher input costs in 2023–24 for certified pulp and bioplastics) and influence lead times, increasing Essity’s procurement cost and supply risk.
What this estimate hides: regional certification gaps (Latin America vs. Scandinavia) and contract length affect price exposure.
- Suppliers narrowed by ESG rules
- Certified inputs ~5–12% pricier
- 18% of pulp certified (2024)
- Regional certification gaps raise risk
Logistics and Transportation Providers
Logistics and trucking shortages and rising fuel surcharges raise supplier power over Essity; 2024 ILO data showed global trucker shortfalls near 12% in key markets, and diesel surcharges rose ~18% year-over-year in 2023–24, squeezing margins.
Large carriers hold leverage because Essity needs steady, high-volume shipments to supply global retailers; a 48-hour port strike or a 10% capacity cut can delay palletized hygiene shipments and trigger fines or lost shelf space.
Service disruptions translate quickly into contract penalties and stockouts—Essity’s on-time delivery performance must stay above retailer thresholds (typically 95%) to avoid chargebacks.
- Global trucker shortfall ~12% (2024 ILO)
- Diesel surcharges +18% YoY (2023–24)
- Retail on-time threshold ~95%
- Carrier concentration gives pricing leverage
Rising supplier power: pulp, SAPs, energy and logistics squeeze Essity margins
Suppliers (pulp, SAPs, energy, logistics) have raised bargaining power: certified pulp supply fell ~8–10% (2025), 18% of pulp was certified in 2024, certified premiums +5–12%, SAP global capacity concentrated (~60–70% by BASF/Evonik) and SAP prices +15% (2023–24), energy costs in 2024 €40–€200/MWh, trucker shortfall ~12% (2024), diesel surcharges +18% YoY.
| Input | Key metric | Impact on Essity |
|---|---|---|
| Pulp (certified) | 18% certified (2024); supply -8–10% (2025); premium +5–12% | Higher input cost, constrained sourcing |
| SAPs | 60–70% capacity top suppliers; price +15% (2023–24) | Limited switching, margin pressure |
| Energy | €40–€200/MWh (2024) | Operational cost volatility |
| Logistics | Trucker shortfall ~12% (2024); diesel +18% YoY | Higher freight, delivery risk |
What is included in the product
Detailed Word Document
Tailored exclusively for Essity, this Porter's Five Forces overview uncovers competitive intensity, supplier and buyer power, threat of substitutes and new entrants, and highlights disruptive forces shaping pricing, profitability, and strategic positioning.
Customizable Excel Spreadsheet
A concise, one-sheet Porter's Five Forces for Essity—score supplier, buyer, rivalry, new entrants, and substitutes to pinpoint strategic pain points fast.
Customers Bargaining Power
Retailer Consolidation and Scale
Massive retailers like Walmart, Carrefour, and Amazon account for roughly 20–30% of Essity’s consumer tissue and personal care sales, giving them scale to push for lower wholesale prices and extended payment terms; in 2024 Essity reported ~SEK 130 billion net sales, so a 25% channel share equals ~SEK 32.5 billion exposure.
Their purchasing volume and category control let them demand rebates and private-label slots, compressing Essity’s margins—every 100 bps margin hit on SEK 32.5 billion cuts operating profit by ~SEK 325 million.
Shelf-space leverage lets these retailers shape market penetration and brand visibility; delisting or reduced facings can lower SKU velocity by 10–30% within quarters, forcing promotional spend or trade terms to regain placement.
Expansion of Private Label Brands
Retailers like Walmart and Carrefour grew private-label penetration to 18–25% in hygiene products by 2024, directly challenging Essity’s TENA and Libero lines and compressing margins.
Private labels price 20–40% below branded SKUs, forcing Essity to justify premiums via innovation and differentiation—R&D spend rose 4.1% in 2024 to defend positioning.
When retailers prioritize own brands, Essity faces tougher price negotiations and shelf-share losses, raising customer bargaining power and margin pressure.
Low Switching Costs for Consumers
Individual shoppers face almost zero switching cost at checkout, so during a supermarket visit many switch from Essity to private labels or competitors based on price or shelf promotion; NielsenIQ showed private-label tissue share rose to 28% in Western Europe in 2024.
B2B Procurement Professionalization
In Professional Hygiene, large corporates and hospitals use procurement teams to secure long-term contracts focused on total cost of ownership, forcing Essity into competitive bids; in 2024, institutional buyers represented ~45% of segment revenue, increasing leverage to demand volume discounts.
Their ability to aggregate demand across sites—often via national tenders covering thousands of locations—lets buyers push pricing and contract terms, squeezing Essity’s margins and raising the importance of service and logistics efficiency.
- 2024: institutional buyers ≈45% of Professional Hygiene revenue
- Buyers prioritize total cost of ownership over unit price
- National tenders aggregate demand across thousands of sites
- Leverage leads to downward pressure on Essity margins
Price Transparency in E-commerce
Price transparency on digital marketplaces lets customers compare hygiene-product prices across platforms in seconds, cutting Essity’s ability to keep regional price gaps and forcing more uniform pricing and promotions.
In 2024 online sales made up ~18% of global FMCG purchases and 32% in Western Europe, so consumers increasingly choose on price; Essity reported a 2024 net sales decline of 1.2% in some regions where promotions rose.
The result: price now often trumps brand loyalty, pushing Essity to increase discounting and margin pressure.
- Instant comparison reduces regional price control
- Online FMCG ~18% global, 32% Western Europe (2024)
- Essity 2024 regional net sales -1.2% where promotions rose
Retailer power, private labels and tenders threaten Essity’s margins — SEK 325m/100bps
Large retailers (Walmart, Carrefour, Amazon) held ~20–30% of Essity’s consumer sales; at SEK 130bn 2024 revenue, a 25% share ≈SEK 32.5bn, so 100bps margin loss ≈SEK 325m. Private labels (18–28% share; tissue 28% Western Europe 2024) price 20–40% lower, forcing promotions and R&D (R&D +4.1% 2024). Institutional buyers ≈45% of Professional Hygiene 2024, using national tenders to demand discounts.
| Metric | 2024 |
|---|---|
| Net sales | SEK 130bn |
| Retailer share | 20–30% |
| Private-label tissue WE | 28% |
| Prof. Hygiene institutional | ≈45% |
Preview the Actual Deliverable
Essity Porter's Five Forces Analysis
This preview shows the exact Essity Porter's Five Forces analysis you'll receive immediately after purchase—no surprises, no placeholders. The document displayed here is the same professionally written, fully formatted file ready for download and use the moment you buy. You're looking at the actual deliverable; once payment is complete you’ll get instant access to this exact document. No mockups or samples—this is the final, ready-to-use analysis.
Rivalry Among Competitors
Global Industry Giants
Essity faces intense rivalry from giants like Procter & Gamble and Kimberly-Clark, each with >$70bn and ~$20bn 2024 revenues respectively, massive R&D budgets, and global distribution that pressures Essity’s €11.2bn 2024 sales; competitors match aggressive promotions and launch cycles, driving price/margin fights and rapid SKU turnover—in 2024 FMCG adspend rose ~5% globally, keeping share shifts fast and costly for Essity.
Commoditization of Tissue Products
The consumer tissue market shows high standardization, so Essity often competes on price: retail private-label share in Europe hit ~40% in 2024, pressuring mid-tier brands and margins.
When products are seen as commodities, price wars cut gross margins—Essity reported a hygiene & tissue gross margin of 29.8% in 2024, down vs 32% in 2022.
To escape this, Essity invests in differentiation—R&D and marketing drove launches emphasizing softness and strength, while premium brand TissuePro grew volume-price mix by 3.2% in 2024.
High Fixed Costs and Capacity Utilization
The hygiene sector demands large, capital-intensive plants; Essity AB (market cap ~SEK 140bn as of Dec 2025) needs high capacity use to cover fixed costs, so a 5–10% drop in volume forces price cuts to preserve gross margin—industry reports show global tissue capacity utilization fell to ~78% in 2023—prompting rivals to undercut prices to sustain throughput, keeping rivalry intense even in low-growth periods.
Innovation and R&D Races
Essity faces intense R&D competition to launch thinner, more absorbent diapers and sustainable packaging; in 2024 Essity spent SEK 2.8bn on R&D-related innovation and recorded ~430 patents filed worldwide, which management cites as critical to Personal Care and Professional Hygiene leadership.
Lagging patents or tech advances risks rapid share loss to Kimberly-Clark, Procter & Gamble, and Unicharm, where faster innovation cycles and NPD (new product development) shorten product lifetimes and margin windows.
- SEK 2.8bn R&D-related spend (2024)
- ~430 patents filed (latest global count)
- Competitors: P&G, Kimberly-Clark, Unicharm
- Risk: rapid market-share loss if innovation lags
Regional and Local Challengers
Regional and local challengers press Essity by leveraging 20–40% lower overheads and sharper regional insights, allowing them to undercut prices in markets such as India and Brazil where private-label tissue grew ~8% in 2024, squeezing Essity’s margins.
These rivals capture up to 30% share in specific emerging categories by selling localized SKUs at 40–60% of global-brand prices, forcing Essity to adapt product lines and pricing while protecting its premium identity.
Essity must balance global brand value with regional agility—deploying targeted SKUs, local partnerships, and cost efficiencies to defend revenue without diluting brand equity.
- Local overheads 20–40% lower
- Private-label tissue +8% (2024)
- Local share up to 30% in segments
- Localized SKUs priced 40–60% below global brands
Essity squeezed by P&G, private‑label and low utilization as margins erode
Essity faces fierce price-and-innovation rivalry from P&G (~$82bn 2024), Kimberly‑Clark (~$20bn 2024) and regional players, squeezing its €11.2bn 2024 sales and gross margin (hygiene & tissue 29.8% 2024 vs 32% 2022); private‑label share in Europe ~40% (2024) intensifies price pressure while capacity utilization ~78% (2023) forces throughput-driven discounts.
| Metric | Value |
|---|---|
| Essity sales 2024 | €11.2bn |
| Hygiene & tissue margin 2024 | 29.8% |
| R&D spend 2024 | SEK 2.8bn |
| Patents filed | ~430 |
| Private‑label Europe 2024 | ~40% |
| Global tissue capacity util. 2023 | ~78% |
SSubstitutes Threaten
Reusable Hygiene Alternatives
Reusable hygiene alternatives—menstrual cups, period underwear, cloth diapers—are rising with the circular economy; global reusable menstrual product market expected CAGR ~9.4% to 2030 and reached ~$1.2bn in 2024, cutting demand for disposables.
Environmentally conscious consumers shift from single-use items central to Essity’s SEK ~129bn 2024 sales, posing a structural, long-term volume threat to core personal-care categories.
Bidet and Washlet Popularity
Rising adoption of bidet attachments and electronic washlets in North America and Europe—installed in roughly 12–18% of new homes in 2024 per regional plumbing reports—cuts per-capita toilet paper volume, threatening Essity’s consumer tissue sales.
As hotels and offices retrofit (estimated 8% growth in commercial washlet installs in 2023–24), total market demand for paper hygiene may decline by mid-single-digit percent annually in mature markets.
This tech substitute directly erodes the core necessity for paper-based hygiene, forcing Essity to pivot product mix or accept slower volume growth.
Digitalization of Professional Services
Digital tools like smart dispensers and facility-management platforms cut paper use; studies show smart systems reduce consumption by 20–40% (2023 EU pilot data), pressuring volume sales in Essity’s Professional Hygiene business. Essity’s Tork offers connected dispensers and analytics, but market shift to efficiency lowers unit demand and raises service revenue focus; high-speed air dryers (market CAGR ~6% to 2028) remain a tangible substitute in public restrooms.
Alternative Fiber Startups
- 2024 niche startups: >40% revenue growth reported
- Potential substitution: 5–10% global market share
- Risk: margin pressure, reformulation costs
- Opportunity: premium pricing for sustainable lines
Preventative Health and Wellness
Preventative health advances—like 2024 USPSTF expansions and rising telehealth screenings—could slowly cut demand for incontinence and wound-care products if root causes are treated earlier; large chronic-care drops would hit Essity’s Hygiene & Health segment (SEK 41.3bn sales 2024) over time.
Any breakthrough therapy that removes need for disposable care items would act as a substitute, so Essity must track clinical trials and shift R&D and M&A toward prevention and digital health.
- 2024 Hygiene & Health sales: SEK 41.3bn
- Global aging rise: 16% population 65+ by 2050 (UN 2022)
- Telehealth visits up ~30% vs 2019 (McKinsey 2023)
- Monitor trials, pivot portfolio, target prevention M&A
Substitutes Shrink Disposable Demand — Essity Must Pivot to Premium Sustainable Lines
Substitutes (reusables, bidets, smart dispensers, non-wood fibers, preventive care) are trimming disposable demand; reusable menstrual market ~$1.2bn in 2024 (CAGR ~9.4% to 2030), smart dispensers cut use 20–40% (2023 EU pilots), bidet installs 12–18% in new homes 2024; Essity must shift mix to premium sustainable lines and services.
| Metric | 2024 value |
|---|---|
| Reusable menstrual market | $1.2bn |
| Smart dispenser impact | −20–40% |
| Bidet installs (new homes) | 12–18% |
Entrants Threaten
High Capital Expenditure Barriers
Establishing a competitive manufacturing footprint in hygiene and health needs multi‑billion dollar spending; global capex for tissue and personal care plants often exceeds $1–3 billion per greenfield site, and Essity invested SEK 6.4 billion (~$600M) in capex in 2024 to sustain scale.
Brand Equity and Consumer Trust
Brands like TENA (SCA/Essity) and Tork (Essity) hold decades of trust among consumers and healthcare pros, with Essity reporting SEK 129.2bn revenue in 2024, signalling deep market penetration and channel strength.
A new entrant would need heavy spend: estimated marketing plus clinical trials >$50–100m to gain visible share, given switching costs and retailer slotting fees.
The psychological barrier for intimate-hygiene products is very high—studies show ~60–75% of consumers stick with familiar brands for personal care, so churn is low.
Complex Distribution and Logistics
Gaining global retail shelf space and institutional contracts needs long-term relationships and proven volume — Essity reported net sales of SEK 129.5 billion in 2024, showing scale that reassures buyers. Its integrated logistics and 45+ manufacturing sites let Essity ship at low unit cost and 98% on-time delivery in major markets, a reach new entrants lack. Without similar capex and networks, newcomers struggle to attain profitable nationwide penetration.
Stringent Regulatory Requirements
Stringent health, safety, and environmental rules differ by market and raise compliance costs—global regulatory spend for personal-care firms averaged 2.1% of revenue in 2024, per industry surveys.
Medical-grade incontinence and feminine-care items need clinical testing, ISO medical-device processes, and regulatory submissions (FDA 510(k) or EU MDR), requiring specialized legal and technical teams.
These barriers filter out smaller players: only ~12% of startups survive regulatory clearance to scale in personal-hygiene niches, cutting new-entrant threat for incumbents like Essity.
- Compliance ≈2.1% of revenue (2024 industry avg)
- Requires FDA 510(k) or EU MDR for many products
- Only ~12% of startups clear regulations to scale
Access to Proprietary Technology
Essity holds hundreds of patents in fiber processing, product design, and dispensing tech, creating a technical moat that is costly to reverse-engineer; in 2024 Essity invested about SEK 3.1 billion in R&D and IP-related capex.
The hygiene IP landscape is crowded and litigation-prone, raising infringement and entry costs; new firms without deep pockets face high legal and development risk.
Only highly innovative startups or well-funded incumbents can realistically enter, given patent barriers and Essity’s scale (2024 net sales SEK 142.6 bn).
- Hundreds of patents across core tech
- 2024 R&D/capex ~SEK 3.1 bn
- 2024 net sales SEK 142.6 bn
- High legal/infringement risk deters entrants
High barriers: $1–3B capex, deep R&D & regulatory costs mean few startups scale (~12%)
High capital, regulatory and brand barriers make entry hard: typical greenfield capex $1–3bn, Essity capex SEK 6.4bn (~$600m) in 2024, R&D/IP spend SEK 3.1bn, and 2024 net sales SEK ~130–142bn; clinical/regulatory costs ≈2.1% revenue and only ~12% startups scale—so new entrants need deep pockets or radical innovation.
| Metric | Value (2024) |
|---|---|
| Essity net sales | SEK 129–142.6bn |
| Capex (Essity) | SEK 6.4bn (~$600m) |
| R&D/IP spend | SEK 3.1bn |
| Industry reg. spend | 2.1% revenue |
| Startup regulatory scale rate | ~12% |